Protocols in progress or published;
- Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma
- Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers
- First-line treatments for people with single or multiple brain metastases
- Immunotherapy for intra-cranial metastatic melanoma
- Immune checkpoint blockade for glioma
- Particles versus photons for the treatment of chordoma
- Perfusion MRI for the differentiation between tumour progression and radiation-induced effects in adults with high-grade glioma
- Site-specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site
- Surgery resection for recurrent high-grade glioma
- Treatment options for progression or recurrence of glioblastoma: a network meta-analysis
Reviews published;
- Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas
- Antiangiogenic therapy for high-grade glioma
- Anti-epidermal growth factor receptor therapy for glioblastoma in adults
- Biopsy versus resection for high grade glioma
- Biopsy versus resection for the management of low-grade gliomas
- Chemotherapy for high-grade glioma
- Chemotherapy wafers for high grade glioma
- Early versus delayed radiotherapy for the treatment of low-grade gliomas
- External beam radiation dose escalation for high grade glioma
- Image guided surgery for the resection of brain tumours
- Interval brain imaging for adults with cerebral glioma
- Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation
- Interventions for the management of fatigue in adults with a primary brain tumour
- Interventions for the treatment of radiation brain necrosis after radiotherapy or radiosurgery
- Interventions to help support caregivers of people with a brain or spinal cord tumour
- Interventions to reduce the time to diagnosis of brain tumours
- Intraoperative imaging technology to maximise extent of resection for glioma
- Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma
- Magnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentation
- Pharmacological treatment of depression in patients with a primary brain tumour
- Procarbazine, lomustine, and vincristine for recurrent high-grade glioma
- Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases
- Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis
- Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases
- Temozolomide for high grade glioma
- Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis
- Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
- Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases